We are live on ! Find out more
JFBI

Jefferson Bancshares
JFBI

Delisted

JFBI was delisted on the 30th of May, 2014.

13 hedge funds and large institutions have $4.83M invested in Jefferson Bancshares in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,808% more capital inflows, than outflows

Capital inflows: $320K | Capital outflows: $8.18K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

13% less funds holding

Funds holding: 15 → 13 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

JFBI Hedge Fund Activity: Q3 2013 in Review

13 of the 3,095 institutional investors tracked by Wall St. Rank reported a position in Jefferson Bancshares (JFBI) for Q3 2013, worth a combined $4.83M — up 9.8% from $4.4M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of JFBI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 5 added.

The largest buyer was Stilwell Value, adding an estimated $210K. The largest seller was Tower Research Capital (TRC), cutting an estimated $5.62K.

  • 13 institutional investors held Jefferson Bancshares (JFBI) as of Q3 2013, down from 15 in Q2 2013.
  • Funds reported $4.83M of Jefferson Bancshares stock for Q3 2013, up 9.8% quarter-over-quarter.
  • 1 fund opened new Jefferson Bancshares positions in Q3 2013 and 2 closed out, a net change of -1 holder.
  • The largest Jefferson Bancshares buyer in Q3 2013 was Stilwell Value, an estimated $210K added.
  • The largest Jefferson Bancshares seller in Q3 2013 was Tower Research Capital (TRC), an estimated $5.62K sold.

Based on aggregated 13F filings for Q3 2013.